Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
PharmaCyte Biotech, Inc. (NVLX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/25/2014 |
8-K
| Resignation/termination of a director|
Docs:
|
"Amendment No. One to the Bylaws of Nuvilex, Inc",
"Settlement Agreement, by and between Nuvilex, Inc. and Robert F. Ryan, M.S., Ph.D",
"Asset Purchase Agreement, by and between Nuvilex, Inc. and Robert F. Ryan, M.S., Ph.D",
"Nuvilex, Inc. Code of Business Conduct and Ethics",
"Nuvilex, Inc. Audit Committee Charter",
"Nuvilex, Inc. Compensation Committee Charter",
"Nuvilex, Inc. Nominating Committee Charter",
"Nuvilex, Inc. Insider Trading Policy",
"Nuvilex, Inc. Software Policies" |
|
|
|